rs67294955

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong

The NM_000531.6(OTC):​c.583G>A​(p.Gly195Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 23)

Consequence

OTC
NM_000531.6 missense

Scores

14
2
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 9.54
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM1
In a strand (size 5) in uniprot entity OTC_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_000531.6
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.996
PP5
Variant X-38403660-G-A is Pathogenic according to our data. Variant chrX-38403660-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 97255.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
OTCNM_000531.6 linkuse as main transcriptc.583G>A p.Gly195Arg missense_variant 6/10 ENST00000039007.5 NP_000522.3 P00480
OTCNM_001407092.1 linkuse as main transcriptc.583G>A p.Gly195Arg missense_variant 8/12 NP_001394021.1
OTCXM_017029556.2 linkuse as main transcriptc.583G>A p.Gly195Arg missense_variant 6/9 XP_016885045.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
OTCENST00000039007.5 linkuse as main transcriptc.583G>A p.Gly195Arg missense_variant 6/101 NM_000531.6 ENSP00000039007.4 P00480
ENSG00000250349ENST00000465127.1 linkuse as main transcriptc.172-262461G>A intron_variant 5 ENSP00000417050.1 B4E171

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ornithine carbamoyltransferase deficiency Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 03, 2023For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects OTC function (PMID: 9609999). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. ClinVar contains an entry for this variant (Variation ID: 97255). This missense change has been observed in individual(s) with OTC deficiency (PMID: 7951259, 9609999, 25433810, 30175132). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 195 of the OTC protein (p.Gly195Arg). -
Pathogenic, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -
not provided Pathogenic:2
Pathogenic, no assertion criteria providedliterature onlyGenMed Metabolism Lab-- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxMay 09, 2024Published functional studies demonstrate this variant is associated with approximately 2.5% residual enzyme activity (PMID: 9609999); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8786061, 34014557, 9286441, 17041896, 17044854, 29623395, 19138872, 22728053, 8112735, 9609999, 28324312, 32934962, 32034732, 32778825, 37593415, 33272297, 30175132, 7951259, 37146589) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.71
D
BayesDel_noAF
Pathogenic
0.79
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.99
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.94
D
MetaRNN
Pathogenic
1.0
D
MetaSVM
Pathogenic
0.92
D
MutationAssessor
Pathogenic
4.6
H
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-8.0
D
REVEL
Pathogenic
0.97
Sift
Uncertain
0.0060
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
1.0
MutPred
0.99
Gain of MoRF binding (P = 0.0211);
MVP
0.99
MPC
1.3
ClinPred
1.0
D
GERP RS
5.9
Varity_R
0.99
gMVP
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs67294955; hg19: chrX-38262913; COSMIC: COSV50001107; API